Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices

Cancer Cytopathology

Volumn 123, Issue 9, 2015, Pages 566-

  Castle, Philip E ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GRADING; CANCER SCREENING; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; COLPOSCOPY; CYTOLOGY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LETTER; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERUS BIOPSY; EARLY DIAGNOSIS; ISOLATION AND PURIFICATION; PAPILLOMAVIRIDAE; PATHOLOGY; PROCEDURES; UTERINE CERVIX TUMOR; VIROLOGY;

EARLY DETECTION OF CANCER; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 84951995699     PISSN: 1934662X     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21572     Document Type: Letter

References (3)

1. Blatt AJ, Kennedy R, Luff RD, Austin RM, Rabin DS,. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices. Cancer (Cancer Cytopathol). 2015; 123: 282-288.
2. Gage JC, Schiffman M, Katki HA, et al., Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test. J Natl Cancer Inst. 2014; 106: dju153.
3. Massad LS, Einstein MH, Huh WK, et al,; ASCCP Consensus Guidelines Conference. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013; 17 (5 suppl 1): S1-S27.